Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Shoulder Innovations, Inc. (SI:NYSE), powered by AI.
Shoulder Innovations, Inc. is currently trading at $18.70. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Shoulder Innovations, Inc. on Alpha Lenz.
Shoulder Innovations, Inc.'s P/E ratio is -4.0.
“Shoulder Innovations, Inc. trades at a P/E of -4.0 (undervalued) with modest ROE of -93.8%.”
Ask for details →Shoulder Innovations, Inc. is a medical technology company focused on shoulder surgical care and joint reconstruction. The company designs and commercializes implant systems intended to address clinical challenges in shoulder arthroplasty, with an emphasis on reducing glenoid loosening—the leading cause of shoulder replacement failure—through its proprietary InSet glenoid design and related instrumentation. Its portfolio spans anatomic and reverse shoulder replacement solutions, aiming to improve implant stability, simplify surgical technique, and enhance operating room efficiency for hospital and ambulatory surgery center settings. By targeting biomechanics and fixation at the glenoid, Shoulder Innovations serves orthopedic surgeons treating degenerative disease, rotator cuff pathology, and complex revisions, supporting a continuum of care from primary procedures to reconstructions. The company’s role in the market centers on specialized innovation within upper-extremity orthopedics, providing differentiated implants and evidence-driven design to improve outcomes and total procedural value for providers and payers.
“Shoulder Innovations, Inc. trades at a P/E of -4.0 (undervalued) with modest ROE of -93.8%.”
Ask for details →Shoulder Innovations, Inc. (ticker: SI) is a company listed on NYSE in the Unknown sector (Unknown). Market cap is $162M.
The current price is $18.7 with a P/E ratio of -4.02x and P/B of 1.15x.
ROE is -93.80% and operating margin is -55.58%. Annual revenue is $47M.